All
Refining Treatment Approaches and Advancements in High-Risk Melanoma
Dr. Vincent Ma discussed the most recent and notable treatment updates for patients with high-risk and advanced melanoma.
Celebrating My Clean Bill of Health After Cancer
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
How ADCs Are Redefining Chemotherapy in Breast Cancer Care
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Finding Freedom and Uncertainty in My Cancer Remission Pause
I’m in remission from small lymphocytic lymphoma and off treatment, savoring this break while learning to live with the uncertainty that still lingers.
Understanding Novel Therapy Utility in HER2+ Breast Cancer Treatment
Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change care for patients in the future.
Monjuvi Combo Reduces Progression Risk in Follicular Lymphoma
Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, according to Dr. Christina Poh.
The Power of Suggestion in Breast Cancer Prevention
A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.
The Evolution of Survivorship After a Lung Cancer Diagnosis
In a candid interview with CURE, Terry Gillespie reflects on how her definition of survivorship has evolved from her lung cancer diagnosis to present day.
Real-World Data Supports Amtagvi’s Benefit in Advanced Melanoma
A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.
Second Opinions Key for Those Newly Diagnosed With GIST
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
Finding Comfort and Connection in the Chemo Lounge
During treatment for chronic lymphocytic leukemia and autoimmune anemia, I found relief and encouragement in a caring conversation with my oncology nurse.
Meaningful Changes to Reduce Environmental Toxicities
Dr. Lorenzo Cohen and Alison Jefferies discuss small yet meaningful changes that patients can make to their home environment to foster a sense of wellness.
Understanding the Science Behind the Monjuvi Approval in Lymphoma
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Identifying Patients Who Will Benefit From Intensified Prostate Cancer Treatment
Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will benefit from intensified treatment.
Facing Breast and Lung Cancer Led Me to a New Purpose in Life
I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive changes in my life.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
A patient on the Monjuvi trial saw lymph nodes shrink 85%, with stable results a year later, supporting the FDA’s recent approval for follicular lymphoma.
Finding Strength During Life After Cervical Cancer
Thirteen years after cervical cancer, I’ve found strength in healing, grief in silence, and hope in sharing the quiet truths of survivorship.
Five Years Since My Lymphoma Diagnosis: What I Know Now
Five years after my lymphoma diagnosis, life looks normal on the outside; however, the fear of recurrence and the reality of cancer never fully fade.
How To Self-Advocate While Combating Insurance Red Tape
Dr. Alexandra Zaleta discussed actionable steps that individuals can take to advocate for a more person-centered insurance practice approach.
Fast Track Status Granted by FDA to TRE-515 in Prostate Cancer
The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic castration-resistant prostate cancer.
Finding Strength and Purpose After Cancer Through Goals and Faith
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Diagnosis Day: What I Felt, What I Learned
I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.
How Survivorship Differs for Men With Metastatic Prostate Cancer
Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone living with metastatic disease.
Long-Term Outcomes Support NCCN Guidelines for Prostate Cancer
Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural causes than from their cancer.
Saying Goodbye to My Sister With Hodgkin Lymphoma
After nearly 11 years of living with Hodgkin lymphoma, my sister Kathleen passed away peacefully at 39, leaving me to navigate the sorrow of losing her.
Erleada May Be a New Standard of Care for Some With Prostate Cancer
Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic castration-sensitive prostate cancer.
FDA OKs New Test to Match Lung Cancer Patients With Targeted Therapies
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy.
How Does CAR T-Cell Therapy Work in Hematologic Malignancies?
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia.
Layers of Pain: Decoding the Multifaceted Toxicity of Breast Cancer
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.
